Bayer Offers Concessions in $66 Billion Monsanto Deal to Ease Competition Concerns
Bayer has already agreed to major asset sales to get the greenlight from competition regulators.

Bayer AG (BAYRY) submitted commitments to ease competition concerns to the European Commission in the hopes it can avoid a lengthy review process associated with its $66 billion takeover of agrochemicals group Monsanto (MON) , Reuters reported.

The Commission extended the deadline for its initial review of the German chemical maker's deal, hoping to complete it by August 22. Bayer expects the deal with Monsanto to close by the end of the year.

Bayer has already agreed to major asset sales to get the greenlight from competition regulators. The company didn't say what it offered in the latest concessions.

The sector has seen significant concessions from companies looking to win competition approval for deals, including commitments made in Dow Chemical (DOW) and DuPont's (DD) merger and ChemChina's purchase of Syngenta (SYT) . Both deals were subject to full-scale probes.

Bayer and Monsanto stocks traded slightly up midday.

Dow Chemical is a holding in Jim Cramer's Action Alerts PLUS Charitable Trust Portfolio . Want to be alerted before Cramer buys or sells DOW? Learn more now.

More of What's Trending on TheStreet:

More from Stocks

Santa Claus Rally? Machines Render Old Stock Market Adages Worthless

Santa Claus Rally? Machines Render Old Stock Market Adages Worthless

Procter & Gamble Helps Lead Dow Jones After Upgrade From Morgan Stanley

Procter & Gamble Helps Lead Dow Jones After Upgrade From Morgan Stanley

Hey Investors, Don't Let the Bad Times Pollute Your Mind

Hey Investors, Don't Let the Bad Times Pollute Your Mind

Make This Dividend Aristocrat a Staple of Your Portfolio

Make This Dividend Aristocrat a Staple of Your Portfolio

Join Jim Cramer's Club During Our '12 Days of Holiday Deals' Sale and Save 66%!

Join Jim Cramer's Club During Our '12 Days of Holiday Deals' Sale and Save 66%!